Science. Networks. Delivery.

Who we are

Julius Clinical is a therapeutically specialized CRO. Science is the foundation of all we do.

Our renowned scientific leaders are at the forefront of their fields. Combined with our site networks and delivery, it enables Julius Clinical to provide clients with a tailor-made solution for their clinical trial.

Where we come from

Julius Clinical spun off from the UMC Utrecht in 2008.

Our approach as a therapeutically specialized CRO is based on our scientific roots. We work closely with internationally recognized scientific leaders to solidify our scientific expertise and credibility.

What we do

Science is what we do.

Julius Clinical specialises in well-defined areas to constantly expand on our delivery and scientific collaborations in those areas. That is how we make a difference in the world of clinical trials.

Who we are

Julius Clinical is a therapeutically specialized CRO. Science is the foundation of all we do.

Our renowned scientific leaders are at the forefront of their fields. Combined with our site networks and delivery, it enables Julius Clinical to provide clients with a tailor-made solution for their clinical trial.

Where we come from

Julius Clinical spun off from the UMC Utrecht in 2008.

Our approach as a therapeutically specialized CRO is based on our scientific roots. We work closely with internationally recognized scientific leaders to solidify our scientific expertise and credibility.

What we do

Science is what we do.

Julius Clinical specialises in well-defined areas to constantly expand on our delivery and scientific collaborations in those areas. That is how we make a difference in the world of clinical trials.

Our unique triangle

To improve health in our therapeutic areas of expertise through clinical research that is deeply rooted in medicine.


To be the role model for and the market leader in the clinical research industry. We will do this by focusing on our core strengths:

  • Providing independent, innovative, and high-quality clinical services to our clients and scientific institutions
  • Responding to the challenges of the pharmaceutical industry by delivering scientifically credible, creative, and tailor-made alternatives for current clinical research practices
  • Developing and publishing clinical research on innovative products that impact medicine

Surprising
We do things differently. With our scientific approach and surprisingly customer-centric culture, we deliver the best possible study experience for Sponsors. Don’t be surprised if we don’t suggest the obvious. We exceed expectations and make a difference in our well-defined therapeutic focus areas.

Flexible
We work in a dynamic market. Every day we need to adapt to meet the expectations of our clients. Our flexibility and imagination help us find best-fit solutions that meet or exceed industry standards for quality.

Passionate
We bring a passionate approach to a business environment. With relentless dedication, a deep well of energy, and entrepreneurial drive, we commit ourselves to tailor-made clinical trials that impact lives around the world.

Best in class
We were born out of academia research, and we use science to support sponsors to define and achieve their medical endpoints. We combined this with our entrepreneurial mindset to become a leading service provider in conducting global clinical trials in well-defined therapeutic areas.

Trustworthy
We are well-positioned as a trustworthy clinical research partner because of our scientific and medical knowledge, highly qualified employees, strong relationships with leading experts, and access to global research networks. As a result, we have a strong track record of high-quality, innovative, and tailor-made clinical trials within our well-defined therapeutic areas.

Engaged employer
We are a Dutch company with an open and direct — but warm — culture. Combined with our many colleagues around the world, we look after each other and place great importance on collaboration and cooperation. This culture drives us to perform at our best every day.


Management Team

When you partner with us, you leverage the deep scientific experience of an therapeutically specialized CRO. Our teams consist of scientific thought leaders with proven records of clinical research expertise, as well as highly qualified operational experts.

Rick grobbee
Merel schoonmade

Key Opinion Leaders

At Julius Clinical, we are committed to delivering the highest level of expertise in every therapeutic area we cover. By collaborating closely with key opinion leaders, we ensure that our research and clinical trials are guided by the most current and comprehensive knowledge available. This partnership allows us to offer unparalleled insights and innovative solutions, ultimately advancing healthcare and improving patient outcomes.

ALS

Prof. Leonard van de berg

Prof. dr. Leonard van den Berg is a neurologist at University Medical Centre (UMC) Utrecht and ALS Centrum. He is experienced in conducting global ALS trials, established the prominent TRICALS site network, and is chair of the European Network for the Cure of ALS.

Dementia Scientific Advisory Board

Prof. Dr. Philip Scheltens

Prof. Dr. Philip Scheltens, who gained his MD and PhD from VU University Amsterdam, founded and directed the Alzheimer Center at Amsterdam UMC until 2022. He currently heads the Dementia Fund at EQT Life Sciences, has authored over 1250 peer-reviewed papers, and serves as chair of the World Dementia Council.

Dementia Scientific Advisory Board

Prof. John Harrison

Professor John Harrison, Chief Scientific Officer at Scottish Brain Sciences, is a renowned cognition expert with 25 years of experience aiding over 80 CNS drug development organizations. He developed the Neuropsychological Test Battery for Alzheimer’s studies, contributed to Brintellix’s development, and has authored over 100 scientific works. He is an Associate Professor at AUmc Alzheimer Center and Visiting Professor at King’s College London.

Epilepsy

Prof. dr. Eigen Trinka

Prof. Dr. Eugen Trinka is the chair of the Neurology Department at Paracelsus Medical University Salzburg and the president-elect of the Austrian Society of Neurology.

Parkinson's Disease

Prof. dr. Teus van Laar

Prof. dr. Teus van Laar is Professor of Neurology, Advanced treatment of Parkinson’s disease, at the UMC Groningen. He is an experienced clinical trialist. In addition he is Director of Parkinon’s disease Platform Northern Netherlands, Board member of the Dutch Parkinson Scientists and Vice-chair of the Scientific Advisory Board of Parkinson NL.

Parikson's Disease

Prof. Fabrizio Stocchi

Prof. Fabrizio Stocchi, a Full Professor of Neurology at IRCCS San Raffaele Rome and University “La Sapienza,” holds MD and Ph.D. degrees from prestigious Italian universities. His research in neuropharmacology focuses on Parkinson’s disease, yielding numerous publications. He also advises the Institute for Parkinson’s Disease Research in Vicenza and is a member of multiple neurological societies.

Hearing Loss

Prof. dr. Anne Schilder

Prof. dr. Anne Schilder from Ear Institute at University College London (UCL) is senior investigator and leader of NIHR UCLH Biomedical Research Centre’s programme for translational hearing. She is a world leader in ENT research.

Cardio-metabolic and renal diseases

Prof. dr. Christophe Moreno, M.D.

Christophe is a professor in gastroenterology and hepatology and clinical director of the liver unit at CUB Hôpital Erasme, Brussels, Belgium. He is an important consultant to the NASH Clinical team.

Cardio-metabolic and renal diseases

Prof. Hiddo Lambers Heerspink

Prof. Hiddo Lambers Heerspink, a clinical pharmacologist at the University Medical Center Groningen, specializes in nephrology. His research focuses on kidney disease treatment and developing new therapies. He is internationally recognized for his extensive publications and contributions to nephrology, and he participates in global research projects to improve patient outcomes.

Infectious diseases and immunology

Dr. Louis Bont

Dr. Louis Bont is a prominent pediatrician specializing in infectious diseases. He is a professor at the University Medical Center Utrecht in the Netherlands and a leading expert in respiratory syncytial virus (RSV) research. Dr. Bont has published extensively on RSV and other pediatric infectious diseases, contributing significantly to the understanding and management of these conditions. He is also chair of ReSViNET, an international network focused on RSV research and prevention.

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn